AXZIMO Trademark

Trademark Overview

On Wednesday, August 31, 2022, a trademark application was filed for AXZIMO with the United States Patent and Trademark Office. The USPTO has given the AXZIMO trademark a serial number of 97573032. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, October 18, 2024. This trademark is owned by Laboratoires Thea. The AXZIMO trademark is filed in the Pharmaceutical Products category with the following description:

Ophthalmic preparations for the treatment of glaucoma
axzimo

General Information

Serial Number97573032
Word MarkAXZIMO
Filing DateWednesday, August 31, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, October 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2022

Trademark Statements

Goods and ServicesOphthalmic preparations for the treatment of glaucoma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLaboratoires Thea
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressParis Cedex 17 75847
FR
Party NameLaboratoires Thea
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCLERMONT-FERRAND 63100
FR

Trademark Events

Event DateEvent Description
Saturday, September 3, 2022NEW APPLICATION ENTERED
Wednesday, September 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 28, 2022ASSIGNED TO EXAMINER
Wednesday, September 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 12, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 1, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 6, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 6, 2023SOU EXTENSION 1 FILED
Tuesday, June 6, 2023SOU EXTENSION 1 GRANTED
Thursday, June 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 9, 2023SOU EXTENSION 2 FILED
Thursday, November 9, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 9, 2023SOU EXTENSION 2 GRANTED
Saturday, November 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 29, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, May 29, 2024SOU EXTENSION 3 GRANTED
Thursday, May 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 29, 2024SOU EXTENSION 3 FILED
Friday, October 18, 2024SOU TEAS EXTENSION RECEIVED
Friday, October 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 18, 2024SOU EXTENSION 4 GRANTED
Friday, October 18, 2024SOU EXTENSION 4 FILED

Related Keywords

axzimo glaucoma treatment preparations ophthalmic